|
BMY | Bristol Myers Squibb Co |
|
|
BMY | Bristol Myers Squibb Co |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.46 |
| Leverage | 81.91% |
| Market Cap | $ 109.0B |
| PE | 0.00 |
| Dividend Yield | 4.36% |
| Profit | $ -6.6B |
| Margin | -14.19% |
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.